leoyeh2019
  • NEW!
    NEW!  Connect Ideas Across Notes
    Save time and share insights. With Paragraph Citation, you can quote others’ work with source info built in. If someone cites your note, you’ll see a card showing where it’s used—bringing notes closer together.
    Got it
      • Create new note
      • Create a note from template
        • Sharing URL Link copied
        • /edit
        • View mode
          • Edit mode
          • View mode
          • Book mode
          • Slide mode
          Edit mode View mode Book mode Slide mode
        • Customize slides
        • Note Permission
        • Read
          • Only me
          • Signed-in users
          • Everyone
          Only me Signed-in users Everyone
        • Write
          • Only me
          • Signed-in users
          • Everyone
          Only me Signed-in users Everyone
        • Engagement control Commenting, Suggest edit, Emoji Reply
      • Invite by email
        Invitee

        This note has no invitees

      • Publish Note

        Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note No publishing access yet

        Your note will be visible on your profile and discoverable by anyone.
        Your note is now live.
        This note is visible on your profile and discoverable online.
        Everyone on the web can find and read all notes of this public team.

        Your account was recently created. Publishing will be available soon, allowing you to share notes on your public page and in search results.

        Your team account was recently created. Publishing will be available soon, allowing you to share notes on your public page and in search results.

        Explore these features while you wait
        Complete general settings
        Bookmark and like published notes
        Write a few more notes
        Complete general settings
        Write a few more notes
        See published notes
        Unpublish note
        Please check the box to agree to the Community Guidelines.
        View profile
      • Commenting
        Permission
        Disabled Forbidden Owners Signed-in users Everyone
      • Enable
      • Permission
        • Forbidden
        • Owners
        • Signed-in users
        • Everyone
      • Suggest edit
        Permission
        Disabled Forbidden Owners Signed-in users Everyone
      • Enable
      • Permission
        • Forbidden
        • Owners
        • Signed-in users
      • Emoji Reply
      • Enable
      • Versions and GitHub Sync
      • Note settings
      • Note Insights New
      • Engagement control
      • Make a copy
      • Transfer ownership
      • Delete this note
      • Save as template
      • Insert from template
      • Import from
        • Dropbox
        • Google Drive
        • Gist
        • Clipboard
      • Export to
        • Dropbox
        • Google Drive
        • Gist
      • Download
        • Markdown
        • HTML
        • Raw HTML
    Menu Note settings Note Insights Versions and GitHub Sync Sharing URL Create Help
    Create Create new note Create a note from template
    Menu
    Options
    Engagement control Make a copy Transfer ownership Delete this note
    Import from
    Dropbox Google Drive Gist Clipboard
    Export to
    Dropbox Google Drive Gist
    Download
    Markdown HTML Raw HTML
    Back
    Sharing URL Link copied
    /edit
    View mode
    • Edit mode
    • View mode
    • Book mode
    • Slide mode
    Edit mode View mode Book mode Slide mode
    Customize slides
    Note Permission
    Read
    Only me
    • Only me
    • Signed-in users
    • Everyone
    Only me Signed-in users Everyone
    Write
    Only me
    • Only me
    • Signed-in users
    • Everyone
    Only me Signed-in users Everyone
    Engagement control Commenting, Suggest edit, Emoji Reply
  • Invite by email
    Invitee

    This note has no invitees

  • Publish Note

    Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note No publishing access yet

    Your note will be visible on your profile and discoverable by anyone.
    Your note is now live.
    This note is visible on your profile and discoverable online.
    Everyone on the web can find and read all notes of this public team.

    Your account was recently created. Publishing will be available soon, allowing you to share notes on your public page and in search results.

    Your team account was recently created. Publishing will be available soon, allowing you to share notes on your public page and in search results.

    Explore these features while you wait
    Complete general settings
    Bookmark and like published notes
    Write a few more notes
    Complete general settings
    Write a few more notes
    See published notes
    Unpublish note
    Please check the box to agree to the Community Guidelines.
    View profile
    Engagement control
    Commenting
    Permission
    Disabled Forbidden Owners Signed-in users Everyone
    Enable
    Permission
    • Forbidden
    • Owners
    • Signed-in users
    • Everyone
    Suggest edit
    Permission
    Disabled Forbidden Owners Signed-in users Everyone
    Enable
    Permission
    • Forbidden
    • Owners
    • Signed-in users
    Emoji Reply
    Enable
    Import from Dropbox Google Drive Gist Clipboard
       Owned this note    Owned this note      
    Published Linked with GitHub
    • Any changes
      Be notified of any changes
    • Mention me
      Be notified of mention me
    • Unsubscribe
    # Virology(RNA virus) ###### tags: `共筆` <h2 id="Picorna">Picornavirus</h2> ### Picornaviridae family * <a href="#Enteroviruses">Enterovirus (腸病毒)</a> * <a href="#Poliovirus">Poliovirus (小兒麻痺病毒)</a> * Coxsackie A & B * Echovirus * Hepatovirus * Hepatitis A virus (A型肝炎病毒) * <a href="#Rhinovirus">Rhinovirus (鼻病毒)</a> ### Property * Naked, small, <font color="limegreen">icosahedral capsid</font> * <font color="red">**+ssRNA**</font> * Resistant to pH~9, detergents, mild sewage treatment & heat > 可以經由**糞口傳染** > Except: Rhinovirus在酸中不穩定、最適生長溫度為33度 * Most viruses are <font color="red">cytolytic</font>. * Viral RNA is translated into <font color="red">polyprotein</font>. ### Life cycle #### Genome structure * 5' Noncoding Region * VPg * Covalently linked to the 5’ end of the genome * 留下的**primer** * <font color="red">IRES (internal ribosome entry site)</font> * 促進mRNA轉錄(不需要CAP) * Capsid Proteins * Nonstructural Proteins * **Protein processing** (Cut **polyprotein**) * Host shutoff * Polio2A ^pro^ cleaves **eIF4G**, <font color="red">inactivating most cellular translation</font>. > Polio mRNA用IRES而非5'-cap initiate translation > Causes **cell death** * RNA replication * 3' Noncoding Region (3'-poly(A) tail) #### RNA replication * <font color="red">Cell membrane-associated replication</font> * Viral **RNA polymerase (RdRP)** * Host factors: accessory proteins ![](https://i.imgur.com/iQrmY50.png =600x) --- <h3 id="Enteroviruses">Enteroviruses</h3> * 腸病毒(Enteroviruses)++不常造成腸胃道疾病(Enteric disease)++ * **糞口傳染(fecal-oral route)**: 上呼吸道與口咽(Oropharynx)黏膜 -> Intestines 1. 於口咽部複製、亦會感染在小腸黏膜**培氏斑塊**(**Peyer’s patch**)的淋巴球 3. Primary viremia: blood stream 4. Target tissue (**tissue tropism** &cytolytic capacity ) * Skin: * <font color="red">Hand-foot-and-mouth disease(手口足症)</font> * <font color="red">Rash, herpangina(疱疹性咽峽炎)</font> * Muscle * Myocarditis(心肌炎) * Pericarditis(心包炎) * Brain * Encephalitis(腦炎) * Meninges * Meningitis(腦膜炎) * Liver * Hepatitis(肝炎) 5. Secondary viremia * Viral, rather than immune, **pathologic effects** are responsible for causing disease symptoms. <h3 id="Poliovirus"> Poliovirus</h3> * Asymptomatic illness (>90%) * Abortive poliomyelitis, the **minor illness** (5%): nonspecific febrile illness (高熱病) * Nonparalytic poliomyelitis or **aseptic meningitis**(無菌性腦膜炎) (1-2%): back pain(背痛) and muscle spasms(肌肉痙攣) * Paralytic polio, the **major illness** (0.1% to 2.0%) #### Vaccine * Sabin (沙賓) * **口服,活病毒** * **Life long immunity** * Risk of **vaccine-associated poliomyelitis** * Not safe for immunodeficient patients. * Salk (沙克) * 注射,死病毒 * Lack of induction of secretory Ab.(=>會被感染但不會有臨床症狀) * Need boost for life long immunity. <h3 id="Rhinovirus"> Rhinovirus</h3> * Most important cause of the <font color="red">**common cold**</font> * Optimal replication temperature is 33°C or lower. --- <h2 id="Corona">Coronavirus</h2> ### Property * Enveloped, <font color="orange">helical symmetry capsid</font> * <font color="red">+ ss RNA genome</font> ~30 kb(gene很大的RNA病毒), **5’ capped** and **3’ polyadenylated** * **Glycoprotein**: <font color="red">**可以容忍腸胃道環境**</font>,以**糞口傳遞** * Zoonotic (人畜共通) * Structure * N: Nucleocapsid * Binds to viral RNA * M (E1): Membrane * S (E2): Spike * **Receptor binding and fusion** * E: Small envelope * HE: Hemaglutinin esteras * Involved in **release of virus** from cell ### Life cycle #### Genome organization * 5’-Pol-S-E-M-N-3’ * Gene 1: ORF1a & ORF1b * Non-structural proteins * ORF1a: Viral proteases * ORF1b: Polymerase RNA helicase * Gens 2 to 7: subgenomic mRNAs * Structural proteins #### Transcription * <font color="red">**Ribosomal frameshift**</font>: ORF1a & ORF1ab * Sub-genomic mRNAs share the same 5’ leader sequence and 3’ overlapping sequences > A <font color="red">nested set</font> ![](https://i.imgur.com/6Rf6xUw.png =500x) #### Entry * Receptors for **spike proteins** of ++SARS-CoVand SARS-CoV2++ are <font color="red">**Angiotension-converting enzyme 2 (ACE2)**</font>. (in **upper and lower respiratory tracts**) * Spike protein **needs to be processed** before fusion can occur. > by **Cellular proteases** ![](https://i.imgur.com/uQshERJ.png) ### Disease mechanisms * Human coronavirus infects and kills epithelial cells of the upper respiratory tract. (replicates best at 33~35°C) * SARS-CoV & MERS-CoV replicate at 37°C, kill cells and <font color="red">initiate inflammatory responses</font> in the lung * The **glycoprotein** helps this enveloped virus <font color="red">**survive the gastrointestinal tract**</font>. ### MERS-CoV * **Pneumonia & Renal failure** * Case–fatality rate: 34.4% * Majority of these cases were reported from **Saudi Arabia**. * Occur more readily in the **immunocompromised individuals** or those have another **comorbidity**(合併症). * Receptor: Dipeptyl peptidase 4 (DPP4) * Natural reservoir: dromedary camels ### SARS-CoV-2 (cause of Covid-19) * Beta-coronavirus * Cause <font color="red">ARDS (acute respiratory distress syndrome)</font> #### Transmission for SARS-CoV2 * Respiratory droplets, contact * <font color="red">R~0~</font> (R naught, the basic reproduction number) * the average number of people who will catch a disease from **one contagious person** * Reduce R0 * (social) distancing * Isolating infected * Immunization, preventive antiviral treatment * Test, isolation, contact trancing #### Anti-viral drugs ![](https://i.imgur.com/iZo9FAB.png =500x) * Remdesivir (a nucleotide analogs) --- <h2 id="Calici">Calicivirus</h2> * Naked <font color="limegreen">icosohedral capsid</font>, <font color="red">+ssRNA</font>, with a 5ʹ-terminal VPg and 3ʹ-terminal poly(A) * Causes <font color="red">acute gastroenteritis</font>(急性腸胃炎) * 因為小腸上皮細胞被破壞 * Replication is similar to coronaviruses ### Norovirus (諾羅病毒) * **Norwalk virus (Norwalk agent)** * Resistant to environmental pressure, detergents, drying and acid > 要用漂白水消毒 * 由受汙染的水或食物**糞口傳染** * Cause outbreaks of <font color="red">**gastroenteritis**</font>, **vomiting** * Disease <font color="red">++resolves after 48 hours++</font>, without serious consequences. --- <h2 id="Paramyxo">Paramyxovirus</h2> * <font color="red">-ssRNA</font>, enveloped <font color="orange">helical nucleocapsid</font> * Infection induces <font color="red">**syncytia**</font> (**cell-cell fusion**, ++multinucleated giant cell++) ### Structure * Surface glycoprotein * Larger glycoprotein (HN, H, G) (**viral attachment protein**) * H: Measles virus * HN: Parainfluenza virus 1~4 * G: Metapneumovirus * Smaller glycoprotein (F) (**fusion protien**) * Ribonucleoprotein (RNP) * Virion-associated polymerase * L (large-polymerase) * P (Phosphoprotein) * <font color="orange">Helical nucleocapsid</font> (**RNA plus NP protein**) * <font color="red">Neuraminidase</font> can facilitate **release** (by removing **sialic acid**) * F protein needs to be ++cleaved into F1 and F2++ (Hydrophobic fusion peptide) by a **cellular protease** before it can function in membrane fusion. > Cause cell-cell fusion (<font color="red">**syncytia**</font>) ### Life Cycle * Transcription begins at the exact **3’ end**. * RNA上每段基因間都有<font color="red">**intergenic gap**</font>:有RNA二級結構,RdRP有兩成的機率無法解開而++掉下來++ * 當RNA被N protein bind住:不會產生Gap => RNA replication > <font color="red">High level of N leads encapsidation.</font> ![](https://i.imgur.com/neDz30g.png =500x) * F protein facilitates fusion between membranes at ++physiological pH++ -> **direct fusion** * <font color="red">在membrane組裝</font> ![](https://i.imgur.com/KitL3Ka.jpg =400x) ### Pathogenesis and epidemiology |Virus|Disease|Tansmission| |---|---|---| |<a href="#Measles-virus">Measles virus</a>|Maculopapular rash (<font color="red">rubeola</font>)<br>Complications:<br>&nbsp; Otitis(耳炎), Croup(哮吼), Encephalitis|<font color="red">呼吸道->淋巴組織散佈</font><br>**Life-long immunity**| |<a href="#Parainfluenza-virus">Parainfluenza virus</a>|Mild cold-like symptom|**上呼吸道**感染<br>鮮少造成viremia| |<a href="#Mump-virus">Mump virus</a>|Parotitis (腮腺炎)<br>Orchitis (睪丸炎)<br>Meningoencephalitis(腦膜腦炎)|呼吸道上皮-><font color="red">腮腺</font>| |<a href="#Respiratory-syncytia-virus">Respiratory syncytia virus</a>|**Fatal acute** respiratory tract infection<br>Common cold -> pneumonia|Highly contagious<br><font color="red">Lower respiratory tract</font>| --- <h3 id="Measles">Measles virus</h3>(麻疹病毒) |3C & P (cough, conjunctivitis, coryza, and photophobia) -> Koplik’s spots -> SSPE| |---| 1. Inoculation of <font color="red">respiratory tract</font> 2. Cell-associated (monocyte and lymphocytes) viremia (<font color="red">Lmphatic spread</font>) 3. Wide dissemination * **Conjunctivae** * Respiratory tract * Urinary tract * Small blood vessels * Lymphatic system * CNS 5. <font color="red">T-cell response</font> to virus-infected epithelial cells => **Rash** * <font color="red">**Koplik’s spots**</font> (柯氏斑點) 7. Rarly cause Encephalitis (occurs in 3 ways) * <font color="red">**SSPE: Subcute sclerosing Panencephalitis**</font> (亞急性硬化性泛腦炎) * Virus causes ==<font color="red">immunosuppresion</font>==. > Prompt to other infections > Can last after recovery * Highly contagious, transmitted by **respiratory droplets**. --- <h3 id="Parainfluenza">Parainfluenza virus</h3> * ++Limited to respiratory tract++ * **Coldlike sypmtoms, bronchitis (支氣管炎), croup(哮吼)** * Protective immunity is short duration => **會被重複感染** --- <h3 id="Mump">Mump virus</h3>(腮腺炎病毒) * Inoculation of <font color="red">respiratory tract</font> -> Viremia -> Systemic infection * **Parotid gland** (腮腺): Loacl inflammation, swelling (腫脹) * Pancreas (胰臟): Juvenile diabetes * Testes (睾丸): Orchitis (睪丸炎) #### Measles-Mumps-Rubella Vaccine --- <h3 id="Respiratory syncytia">Respiratory syncytia virus</h3> * ++Respiratory tract local infection++, causes common cold to pneumonia. * Pneumonia results from **cytopathologic** spread of virus (including <font color="red">syncytia</font>) * **呼吸道狹窄**(Narrow airways) in ++infants++ : **formation of plugs** of mucus, fibrin, and necrotic materials --- <h2 id="Rhabdovirus">Rhabdovirus</h2> ### Properties * Rhabdo -- Rod * Enveloped <font color="red">helical nucleocapsid (bullet shape)</font>, simplest, non-segmented <font color="red">-ssRNA</font> virus * Similar genetic organization, transcription, and replication to those of ++Paramyxoviridae and Filoviridae++. * Contains genera: * ++Vesiculovirus++ (vesicular stomatitis virus, VSV, most intensively studied) * ++Lyssavirus++ (**rabies** (狂犬病), rabieslike viruses in animals) ### Life cycle 1. <font color="red">**Receptor mediated endocytosis**</font>: **G protein (glycoprotein)** > Fusion occurs at **acid pH** (enodsome) => 不會有syncytia現象 2. L (RdRp) and P synthesizes mRNA (five monocistronic fragments). 3. Translation: * G is translated by ++ER-bound ribosomes++ * M (Matrix protein), N(nucleocapsid protein), P, and L (RNA polymerase) L are translated by ++free ribosomes++. 4. **High level of N** blocks polyadeynlation and mRNA cleavage => full length +RNA. * There is ++no early/late division++. ![](https://i.imgur.com/IpXMWX8.png =500x) ### Rabies #### Transmission route * <font color="red">Zoonosis</font> (animal to human) * Animal bite * US: bats * Asia: stray dogs * Taiwan: badgers (鼬獾) #### Disease mechanism 1. Virus <font color="red">raplicates in the muscle</font>, with no symptoms (**Incubation phase**) 2. After weeks to month, the virus infects the peripheral nerves and travels up the CNS to the brain (**Prodrome phase**, 前驅期) > 發燒、頭痛、喉嚨痛、疲倦、噁心 4. Infection of the brain (**Neurologic phase**) > <font color="red">Classic brainstem encephalitis (典型的腦幹腦炎)</font>: > 腦神經異常、咽部肌肉收縮的疼痛 => <font color="red">恐水症</font>(hydrophobia) #### Treatment * **Post-exposure prophylaxis**(預防): due to ++long incubation time++ * Clean wound * Vaccination * **Human rabies immune globulin (HRIG)** > 在非疫區,原則不必打疫苗或HRIG,但要打破傷風 * Once symptoms develop, treatment virtually always **unsuccessful**. #### Diagnosis * <font color="red">**Negri bodies**</font> (內基小體): aggregation of viral nucleocapside in neurons --- <h2 id="Orthomyxo">Orthomyxovirus</h2> ### Properties * Ortho - standard; myxo - mucus * <font color="red">**Segmented** -ssRNA virus</font>, <font color="orange">helical symmetry</font>, enveloped * <font color="red">==Replicate in the nucleus==</font> * Influenza: * Influenza A: human and other mammalians (**zoonosis**) * Influenza B: **human only** * Influenza C: mainly human, swine in China #### Structure * <font color="red">Hemagglutinin (血球凝集素, HA)</font>: **Attachment protein**, **Fusion protien** (binding to ++sialic acid++) * <font color="red">Neuraminidase (神經胺酸, NA)</font>: Preventing clumping(結塊) and **facilitating release** ( cleaves the ++sialic acid++) > **Only Influenza A has subtypes**: 18 HA and 11 NA subtypes * <font color="red">M2</font>: Ion channel, important for <font color="red">**uncoating**</font> * RdRP: PA, PB1, and PB2 * RNA: **8 segments** (**helical RNP => RNA+NP**) ### Life cycle #### Transcription * <font color="red">RNA splicing</font> for **M2 and NS2** * <font color="red">Cap snatching(stealing)</font>: * Influenza virus RdRP (PA) has intrinsic **cap-dependent endonuclease** => steal host mRNA CAP => as a **primer** * Genome is ++transcribed into mRNA++ in the <font color="red">**nucleus**</font> ![](https://i.imgur.com/Tx7Z6fJ.png =700x) ### Pathogenesis * Systemic symptoms: **interferon** and **cytokine** response * Local symptoms: **epithelial cell damage** (ciliated and mucus-secreting cells) * <font color="red">Reye syndrome (雷氏症候群)</font>: 幼兒 + 流感 + <font color="red">**Aspirin**</font> => ++嚴重肝和腦的疾病++ * Complications: <font color="red">Bacterial superinfection</font> ### Epidemiology * Spread by inhalation of **small aerosol droplets** * Virus likes a **cool, less humid atmosphere** => winter * High-risk: **Elderly & immunocompromised people** * Major causes of influenza virus- associated death. * **Bacterial pneumonia** * **Cardiac failure** ### Serology * **Antigenic drift** (抗原漂變) * RNA-dependent RNA polymerase has **no proof-reading activity** -> **mutation prone** * **Antigenic shift** (抗原轉移) * Only for <font color="red">influenza A</font> viruses. * **“New” HA or NA proteins** =>宿主從來沒被這個HA或NA感染過 * May cause **pandemics** * <font color="red">Reassortment</font> (segmented viruses) > 兩種型態的病毒同時感染相同細胞時,RNA片段被錯誤包裹到其他病毒 ### Avian influenza viruses * No/limited human to human transmission * H5N1 / H7N9 * Receptor: * Human influenza viruses: sialic acid–a-2,6-Gal(++上呼吸道++) * Avian influenza viruses: sialic acid-a-2,3-Gal(++下呼吸道++) ### Prevention/Treatment #### Durgs |藥物|藥品名|機制|補充| |---|---|---|---| |Rimantadine<br>Amantadine|Flumadine(R)<br>Symadin(R)|M2 inhibitor|Type A only<br>**抗藥性高**| |Zanamivir<br>Oseltamivir|Relenza(R)<br>Tamiflu(R) (**克流感**)|NA inhibitor|Types A and B<br>僅能**緩解症狀**| |Baloxavir marboxil|Xofluza(R) (紓伏效)|inhibit **cap-dependent <br>endonuclease** activity|Types A and B| #### Vaccine * ‘Best guess’ of main antigenic type * A型: H1N1, H3N2 * B型: Yamagata, Victoria * 三價流感疫苗:2A+1B;四價流感疫苗:2A+2B * **Sub-unit vaccine** for children **Reassortant live attenuated vaccine** for healthy persons --- <h2 id="Reo">Reovirus</h2>(呼腸孤病毒) * Orthoreovirus (正呼腸孤病毒) * Orbiviruses (球狀病毒) / Coltiviruses (科羅拉多壁蝨熱病毒) * <a href="#Rotavirus">Rotavirus(輪狀病毒)</a> ### Property * <font color="red">**Double-layered capsid**</font> =>對於++環境抗性非常高++ > Virion is resistant to detergents, acidic pH, drying. * Naked <font color="limegreen">icosahedral symmetry</font> * <font color="red">ds-RNA **segmented** genome</font> (10-12 fragments) * Family has members that infect a **broad range of hosts** from fungi to humans ### Structure * <font color="red">ISVP</font> (Intermediate/Infectious subviral particle) * Proteolytic **cleavage of outercapsid** (in GI tract) activates the virus for infection -> produces an **ISVP (infectious)** * DsRNAs are **never exposed to cytoplasm**.(因為dsRNA會引發很強的免疫反應) ![](https://i.imgur.com/X8ATsJX.png =500x) ### Life cycle ### Entry * **Receptor mediated endocytosis** * **Acid-dependent** proteolytic cleavage (ISVP -> core) #### Transcription * Complete transcription system, including **RdRP**, **5’ capping** and **poly (A) addition** #### Replication * Early phase: mRNAs are synthesized and capped **inside intact cores** and **extruded through channels into the cytosol** > by ++virion enzymes++ * Late phase: Synthesis of double-stranded genome RNAs occurs **within core-like subvirion particles** * 病毒複製發生於<font color="red">**細胞質**</font> * Double-stranded RNA **remains in the inner core** * Gene segments can be <font color="red">reassorted</font> during coinfection of cells by different strains ![](https://i.imgur.com/mekGwwV.png =500x) --- <h3 id="Rota">Rotavirus</h3> (諾羅病毒) * The ++most common cause++ of <font color="red">**severe diarrheal disease**</font> in **infants and young children** worldwide. * <font color="red">NSP4</font> > **Inner capsid protein** > Enterotoxin: **mobilize calcium** and causes **diarrhea** * <font color="red">Reassortment</font> of the 11 gene segments -> **Wide variety** of rotavirus strains * 11 different VP7 antigens (outer capsid) (**G-types**) * 11 different VP4 antigen (outer capsid spike protein) (**P-types**) #### Vaccines * Live, attenuated virus will replicate in the gut #### Epidemiology * Transmitted by **fecal-oral route**. * Rotavirus vaccine is available. * **Live, attenuated virus** will replicate in the gut --- <h2 id="Retro">Retrovirus</h2> ### Classification (based on disease) * <font color="red">Lentiviruses</font> > Slow viruses causing **AIDS** and **neurologic disorders** (**HIV-1, 2**) * Endogenous viruses (HERV) > may take up 1% of human genome ### Property * Enveloped with <font color="red">**two copies (diploid)**</font> of <font color="red">+RNA</font> genome * Have virion associated **RNA-dependent DNA polymerase** (reverse transcriptase) and **integrase** enzymes. * Replicate through a **DNA intermediate** (<font color="red">provirus</font>). * Provirus **integrates randomly into the host genome**. ### Genome structure * Gag (Group-specific antigen) * Capsid protein (CA): <font color="limegreen">icosahedral</font> or conical(圓錐) core * Matrix protein (MP), Nucleocapsid protein(NP) * Pol(DNA polymerase): * **RTase** * RNA-dependent DNA polymerase (**Reverse transcripase**) * DNA-dependent DNA polymerase * **RNase H** * **Integrase** * Protease * Env (Envelope proteins) * Surface protein (SU), Transmembrane protein (TM) * Genome = **mRNA** * ++5'-CAP & 3' poly (A) tail++ * 5’ and 3’ ends: **Repeated sequence** ( R ) * U5 and U3: **Unique regions** ### Life cycle #### Entry * Attach: SU (HIV: **gp120**) * Fusion: TM (HIV: **gp41**) * Receptor: <font color="red">**CD4**</font> * Co-receptor: <font color="red">**CCR5**</font> (M-tropic) or <font color="red">**CXCR4**</font> (T-tropic) #### cDNA synthesis * Primer: <font color="red">**tRNA**</font> * RT: * **RNase H activity** (remove RNA from RNA/DNA) * **DNA polymerase activity**. * Very **error prone** -> variants * <font color="red">LTR (long-terminal repeat)</font> is **duplicated at both ends** of the cDNA: U3, R, U5. ![](https://i.imgur.com/ziuKYAk.png =400x) #### Integration * A copy of cDNA is integrated into the cellular genome at a **random site** #### Transcription * **LTR** contains **promoter** and **enhancer** sequences > U3作為promoter * <font color="red">RNA splicing</font> * Gag/Pol: <font color="red">Polyproteins</font> -> proteolytically by **viral protease** * Env #### Translation (gag-pol fusion) * Gag/Pol polyprotein * Suppression of termination (Gamma retrovirus genus) > About 5-10%, UAG is <font color="red">miss-read</font> as CAG (Gln) * Alternative reading frames (HIV-1) > About 5 % of <font color="red">ribosomes shift</font> #### Assembly * The virus **assembles at the plasma membrane**. * Virus <font color="red">**matures after budding**</font> from the cell after protease (PR) cleaves Gag and Gag-pro precursors. * HIV can also spread from cell to cell through <font color="red">syncytia</font>. ![](https://i.imgur.com/OQzV43E.png =500x) --- <h3 id="HIV">Human immunodeficiency virus (HIV)</h3> ### Property * **Lentivirus** genus * Infect <font color="red">CD4^+^ T cells, macrophages, and dendritic cells</font>. * Receptor: <font color="red">CD4</font> Coreceptor: <font color="red">CXCR4</font> (T-tropic), <font color="red">CCR5</font> (M-Tropic) > **SDF-1** in mucosal membrane blocks **CXCR4** virus infection > People with **CCR5-Δ32** are **resistant** to HIV infection. * AIDS (Acquired Immune Deficiency Syndrome) ### HIV infection 1. HIV binds to **DC-SIGN** 2. Active replication in **lymphoid tissue** 3. Massive **viremia** leads to the wide dissemination of virus 4. Persistent infection (reservoir) 5. Immune response down regulates virus replication (**Asymptomatic**) 6. Large **viremia** 7. <font color="red">**Severe immunodeficiency**, **AIDS dementia**</font> * M-tropic (CCR5, ++non-syncytia-inducing++) **switch to** T-tropic (CXCR4, ++syncytia-inducing++) > due to ++changes in cytokine pattern++ and/or ++mutation of Env gene++ * The infection rapidly destroys CD4 T-cells. * HIV-induced cytolysis * HIV budding * <font color="red">Syncytia</font> (cell-cell fusion) * **Cell permeability ↑** * Apoptosis * <font color="red">**Pyroptosis**</font>: a **highly inflammatory form** of programed cell death, ++caspase 1-dependent++ ### Progression of AIDS-related diseases ![](https://i.imgur.com/Uowv0XH.png =400x) * **AIDS-related complex (ARC)**: Weight loss and malaise, diarrhea, night sweats, and fatigue * **Opportunistic** infection and **recurrent infection** (bacteria, herpes, JC, EBV..) * **Malignancies** (惡性腫瘤) (HHV8-associated **Kaposi’s sarcoma**) * <font color="red">AIDS-related dementia</font>: Infected macrophage and microglial cells **secrete neurotoxic substances** #### Disease mechanism * HIV primary infects **CD4 T cells** & cells of the **myeloid lineage** (包含**微膠細胞(Microglial cells)**) * Virus mutant: CCR5(M-tropic) -> CXCR4(T-tropic) * Lytic infection of virus causes CD4 T cell **apoptosis or pyroptosis** * Causes **syncytia formation** * HIV-1 infecZon leads to increase incidence(發生率) of **malignancy(惡性腫瘤)** > <font color="red">EBV, HHV8 (KSHV), HPV</font> #### Transmission of HIV * Inoculation in blood * Sexual transmission * Perinatal (圍產期) transmission > 分娩前後=>藉由++剖腹產++避免經由產道感染 #### Anti-HIV drugs * Different classed of anti-HIV drugs * Nucleoside analog inhibitor (RTase) * Nonnucleoside RTase inhibitor * Protease inhibitors * Integrase inhibitor * Binding and fusion inhibitor * **No vaccine** and no cure for AIDS. * <font color="red">HAART</font> (highly active antiretrovirus therapy, triple therapy) (雞尾酒療法) * The treatment cannot be discontinued ### Oncogenic retroviruses * 帶有oncogene * 在感染後幾天內便會develop tumor * 不會感染人類 ### Long-latency retrovirus * Caused by virus-encoded regulatory protein controlling transcription * Efficiency of tumor formation is very **low** * Takes **long time** for tumor to develop #### Human T-cell lymphotropic (leukemia) virus (HTLV-1) * Encodes a protein (**tax**) that transactivates gene expression * for growth-stimulating cytokines (IL-2, 3, GMCSF, IL-2 receptor) and LTR-dependent transcription activities. ---

    Import from clipboard

    Paste your markdown or webpage here...

    Advanced permission required

    Your current role can only read. Ask the system administrator to acquire write and comment permission.

    This team is disabled

    Sorry, this team is disabled. You can't edit this note.

    This note is locked

    Sorry, only owner can edit this note.

    Reach the limit

    Sorry, you've reached the max length this note can be.
    Please reduce the content or divide it to more notes, thank you!

    Import from Gist

    Import from Snippet

    or

    Export to Snippet

    Are you sure?

    Do you really want to delete this note?
    All users will lose their connection.

    Create a note from template

    Create a note from template

    Oops...
    This template has been removed or transferred.
    Upgrade
    All
    • All
    • Team
    No template.

    Create a template

    Upgrade

    Delete template

    Do you really want to delete this template?
    Turn this template into a regular note and keep its content, versions, and comments.

    This page need refresh

    You have an incompatible client version.
    Refresh to update.
    New version available!
    See releases notes here
    Refresh to enjoy new features.
    Your user state has changed.
    Refresh to load new user state.

    Sign in

    Forgot password
    or
    Sign in via Google Sign in via Facebook Sign in via X(Twitter) Sign in via GitHub Sign in via Dropbox Sign in with Wallet
    Wallet ( )
    Connect another wallet

    New to HackMD? Sign up

    By signing in, you agree to our terms of service.

    Help

    • English
    • 中文
    • Français
    • Deutsch
    • 日本語
    • Español
    • Català
    • Ελληνικά
    • Português
    • italiano
    • Türkçe
    • Русский
    • Nederlands
    • hrvatski jezik
    • język polski
    • Українська
    • हिन्दी
    • svenska
    • Esperanto
    • dansk

    Documents

    Help & Tutorial

    How to use Book mode

    Slide Example

    API Docs

    Edit in VSCode

    Install browser extension

    Contacts

    Feedback

    Discord

    Send us email

    Resources

    Releases

    Pricing

    Blog

    Policy

    Terms

    Privacy

    Cheatsheet

    Syntax Example Reference
    # Header Header 基本排版
    - Unordered List
    • Unordered List
    1. Ordered List
    1. Ordered List
    - [ ] Todo List
    • Todo List
    > Blockquote
    Blockquote
    **Bold font** Bold font
    *Italics font* Italics font
    ~~Strikethrough~~ Strikethrough
    19^th^ 19th
    H~2~O H2O
    ++Inserted text++ Inserted text
    ==Marked text== Marked text
    [link text](https:// "title") Link
    ![image alt](https:// "title") Image
    `Code` Code 在筆記中貼入程式碼
    ```javascript
    var i = 0;
    ```
    var i = 0;
    :smile: :smile: Emoji list
    {%youtube youtube_id %} Externals
    $L^aT_eX$ LaTeX
    :::info
    This is a alert area.
    :::

    This is a alert area.

    Versions and GitHub Sync
    Get Full History Access

    • Edit version name
    • Delete

    revision author avatar     named on  

    More Less

    Note content is identical to the latest version.
    Compare
      Choose a version
      No search result
      Version not found
    Sign in to link this note to GitHub
    Learn more
    This note is not linked with GitHub
     

    Feedback

    Submission failed, please try again

    Thanks for your support.

    On a scale of 0-10, how likely is it that you would recommend HackMD to your friends, family or business associates?

    Please give us some advice and help us improve HackMD.

     

    Thanks for your feedback

    Remove version name

    Do you want to remove this version name and description?

    Transfer ownership

    Transfer to
      Warning: is a public team. If you transfer note to this team, everyone on the web can find and read this note.

        Link with GitHub

        Please authorize HackMD on GitHub
        • Please sign in to GitHub and install the HackMD app on your GitHub repo.
        • HackMD links with GitHub through a GitHub App. You can choose which repo to install our App.
        Learn more  Sign in to GitHub

        Push the note to GitHub Push to GitHub Pull a file from GitHub

          Authorize again
         

        Choose which file to push to

        Select repo
        Refresh Authorize more repos
        Select branch
        Select file
        Select branch
        Choose version(s) to push
        • Save a new version and push
        • Choose from existing versions
        Include title and tags
        Available push count

        Pull from GitHub

         
        File from GitHub
        File from HackMD

        GitHub Link Settings

        File linked

        Linked by
        File path
        Last synced branch
        Available push count

        Danger Zone

        Unlink
        You will no longer receive notification when GitHub file changes after unlink.

        Syncing

        Push failed

        Push successfully